Skip to main content
SpringerLink
Log in

Interactions with Antiepileptic Drugs

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Most of the currently available antiepileptic drugs have a low therapeutic ratio and therefore a drug interaction causing elevation of the serum level of one of these compounds can readily lead to drug intoxication. Phenytoin, in particular, is vulnerable because its metabolism is dose-related and at therapeutic serum levels the enzyme system involved in its degradation is easily inhibited by concurrent drug administration.

As multiple drug therapy has traditionally been practised in the management of epilepsy, clinically important interactions are common. Furthermore, most of the drugs used in the treatment of major epilepsies are potent inducers of hepatic microsomal enzymes and can therefore stimulate the metabolism of concurrently-administered drugs to such an extent that they may be rendered ineffective. The use of one drug alone is recommended, where possible, in the management of epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahmad, S.: Renal insensitivity to frusemide caused by chronic anticonvulsant therapy. British Medical Journal 3: 657–659 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Braithwaite, R.A.; Flanagan, R.A. and Richens, A.: Steady-state plasma nortriptyline concentrations in epileptic patients. British Journal of Clinical Pharmacology 2: 469–471 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Brooks, S.M.; Werk, E.E.; Ackerman, S.J.; Sullivan, I. and Thrasher, K.: Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. New England Journal of Medicine 286: 1125–1128 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Busfield, D.; Child, K.J.; Atkinson, R.M. and Tomich, E.G.: An effect of phenobarbitone on blood levels of griseofulvin in man. Lancet 2: 1042 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Cereghino, J.J.; Van Meter, J.C.; Brock, J.T.; Penry, J.K.; Smith, L.D. and White, B.G.: Preliminary observations of serum carbamazepine concentration in epileptic patients. Neurology (Minneap.) 23: 357–366 (1973).

    Article  CAS  Google Scholar 

  • Christensen, L.K. and Skovsted, L.: Inhibition of drug metabolism by chloramphenicol. Lancet 2: 1397–1399 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19: 317–366 (1967).

    PubMed  CAS  Google Scholar 

  • Data, J.L.; Wilkinson, G.R. and Nies, A.S.: Interaction of quinidine with anticonvulsant drugs. New England Journal of Medicine 294: 699–702 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Eadie, M.J. and Tyrer, J.H.: Anticonvulsant Therapy. Pharmacological Basis and Practice, p.64 (Churchill Livingstone, Edinburgh 1974).

    Google Scholar 

  • Edwards, V.E. and Eadie, M.J.: Clonazepam —clinical study of its effectiveness as an anticonvulsant. Proceedings of the Australian Association of Neurology 10: 61–66 (1973).

    CAS  Google Scholar 

  • Fincham, R.W.; Schottelius, D.D. Sahs, A.L.: The influence of diphenylhydantoin on primidone metabolism. Archives of Neurology (Chicago) 30: 259–262 (1974).

    Article  CAS  Google Scholar 

  • Hansen, J.M.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Dicoumarol-induced diphenylhydantoin intoxication. Lancet 2: 265–266 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Hansen, J.M.; Kristensen, M. and Skovsted, L.: Sulthiame (Ospolot) as inhibitor of diphenylhydantoin metabolism. Epilepsia (Amsterdam) 9: 17–22 (1968).

    Article  CAS  Google Scholar 

  • Hansen, J.M.; Siersbaek-Nielsen, K.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Effect of diphenylhydantoin on the metabolism of dicoumarol in man. Acta Neurologica Scan-dinavica 189: 15–19 (1971).

    CAS  Google Scholar 

  • Hempel, E. and Klinger, W.: Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications. Drugs 12: 442–448 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Houghton, G.W. and Richens, A.: Inhibition of phenytoin metabolism by sulthiame in epileptic patients. British Journal of Clinical Pharmacology 1: 59–66 (1974a).

    Article  PubMed  CAS  Google Scholar 

  • Houghton, G.W. and Richens, A.: Phenytoin intoxication induced by sulthiame in epileptic patients. Journal of Neurology, Neurosurgery and Psychiatry 37: 275–281 (1974b).

    Article  CAS  Google Scholar 

  • Houghton, G.W. and Richens, A.: The effect of benzodiazepines and pheneturide on phenytoin metabolism in man. British Journal of Clinical Pharmacology 1: 344–345 (1974c).

    Google Scholar 

  • Huisman, J.W.; van Heycop Ten Ham, M.W. and van Zijl, C.H.W.: Influence of ethylphenacemide on serum levels of other antiepileptic drugs. Epilepsia (Amsterdam) 11: 207–215 (1970).

    Article  CAS  Google Scholar 

  • Johannessen, S.I. and Strandjord, R.E.: The influence of phenobarbitone and phenytoin on carbamazepine serum levels; in Schneider et al. (Eds) Clinical Pharmacology of Antiepileptic Drugs (Springer-Verlag, Heidelberg 1976).

    Google Scholar 

  • Karlin, J.M. and Kutt, H.: Acute diphenylhydantoin intoxication following halothane anaesthesia. Journal of Paediatrics 76: 941 (1970).

    Article  CAS  Google Scholar 

  • Karlsson, E.; Collste, P. and Rawlins, M.D.: Plasma levels of lignocaine during combined treatment with phenytoin and procainamide. European Journal of Clinical Pharmacology 7: 455–459 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Kater, R.M.H.; Roggin, G.; Tobon, F.; Zieve, P. and Iber, F.L.: Increased rate of clearance of drugs from the circulation of alcoholics. American Journal of the Medical Sciences 258: 35–39 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Kutt, H.; Winters, W. and McDowell, F.: Depression of parahydroxylation of diphenylhydantoin by antituberculous chemotherapy. Neurology (Minneapolis) 16: 594–602 (1966).

    Article  CAS  Google Scholar 

  • Kutt, H.: Diphenylhydantoin. Interactions with other drugs in man; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p. 168 (Raven Press, New York 1972).

    Google Scholar 

  • Kutt, H.: Biochemical and genetic factors regulating Dilantin metabolism in man. Annals of the New York Academy of Science 179: 704–722 (1971).

    Article  CAS  Google Scholar 

  • Kutt, H.: Interactions of antiepileptic drugs. Epilepsia (New York) 16: 393–402 (1975).

    CAS  Google Scholar 

  • Kutt, H. and McDowell, F.: Management of epilepsy with diphenylhydantoin. Journal of the American Medical Association 203: 969–972 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Laenger, H. and Detering, K.: Antiepileptic drugs and failure of oral contraceptives. Lancet 2: 600 (1974).

    Article  Google Scholar 

  • Lancet Annotation: Paracetamol hepatotoxicity. Lancet 2: 1189 (1975).

    Google Scholar 

  • Latham, A.N.: Some observations on the value of serum drug concentrations and urinary D-glucaric acid determinations in assessing the effects of some anticonvulsant drugs on hepatic enzyme activity. Ph.D. Thesis, University of London (1974).

  • Latham, A.N. and Richens, A.: Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone? British Journal of Clinical Pharmacology 47: 615P (1973).

    CAS  Google Scholar 

  • Levi, A.J.; Sherlock, S. and Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 2: 1275–1279 (1968).

    Article  Google Scholar 

  • Loga, S.; Curry, S. and Lader, M.: Interactions of orphenadrine and phenobarbitone with chlorpromazine; plasma concentrations and effects in man. British Journal of Clinical Pharmacology 2: 197–208 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Lunde, P.K.M.; Rane, A.; Yaffe, S.J.; Lund, L. and Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in man. Clinical Pharmacology and Therapeutics 11: 846–855 (1970).

    PubMed  CAS  Google Scholar 

  • Lusins, J.D. and Jutkowitz, R.: Residual cerebellar systems dysfunction and peripheral neuropathy after diphenylhydantoin therapy. Mount Sinai Journal of Medicine 39: 617–621 (1972).

    PubMed  CAS  Google Scholar 

  • MacDonald, M.G. and Robinson, D.S.: Clinical observations of possible barbiturate interference with anticoagulation. Journal of the American Medical Association 204: 97–100 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Meikle, A.W.; Jubiz, W.; Matsukura, S.; West, C.D. and Tyler, F.H.: Effects of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man. Journal of Clinical Endocrinology and Metabolism 29: 1553–1558 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Mezey, E.: Ethanol metabolism and ethanol-drug interactions. Biochemical Pharmacology 25: 869–975 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Olesen, O.V.: The influence of disulfiram and calcium carbide on the serum diphenylhydantoin. Excretion of HPPH in the urine. Archives of Neurology (Chicago) 16: 642–644 (1967).

    Article  CAS  Google Scholar 

  • Padgham, C. and Richens, A.: Quinine metabolism: a useful index of hepatic drug metabolising capacity in man? British Journal of Clinical Pharmacology 1: 352–353 (1974).

    CAS  Google Scholar 

  • Penttilä, O.; Neuvonen, P.J.; Aho, K. and Lehtovaara, R.: Interaction between doxycycline and some antiepileptic drugs. British Medical Journal 2: 470–472 (1974).

    Article  PubMed  Google Scholar 

  • Petruch, F.; Schüppel, R.V.A. and Steinhilber, G.: Effect of diphenylhydantoin on hepatic drug hydroxylation. European Journal of Clinical Pharmacology 7: 281–285 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Pugh, R.N.H.; Geddes, A.M. and Yeoman, W.B.: Interaction of phenytoin and chlorpheniramine. British Journal of Clinical Pharmacology 2: 173–174 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Rawlins, M.D.; Collste, P.; Bertilsson, L. and Palmer, L.: Distribution and elimination kinetics of carbamazepine in man. European Journal of Clinical Pharmacology 8: 91–96 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Reynolds, E.H.; Fenton, G.; Fenwick, P.; Johnson, A. and Laundy, M.: Interaction of phenytoin and primidone. British Medical Journal 2: 594–595 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Richens, A.: A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients and the development of a nomogram for making dose increments. Epilepsia 16: 627–646 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Richens, A.: Drug Treatment of Epilepsy (Henry Kimpton, London 1976).

    Google Scholar 

  • Richens, A. and Ahmad, S.: Controlled trial of sodium valproate in severe epilepsy. British Medical Journal 4: 255–256 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Richens, A. and Houghton, G.W.: Effect of drug therapy on the metabolism of phenytoin; in Schneider et al. (Eds) Clinical Pharmacology of Anti-Epileptic Drugs (Springer-Verlag, Heidelberg 1975).

    Google Scholar 

  • Richens, A. and Houghton, G.W.: Drug combinations and interactions in severe epilepsy. Proceedings of 6th International Symposium on Epilepsy. Brussels, September 15–18 (1976).

    Google Scholar 

  • Richens, A.; Scoular, I.T.; Ahmad, S. and Jordan, B.J.: Pharmacokinetics and efficacy of Epilim in patients receiving long-term therapy with other antiepileptic drugs; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy (MCS Consultants, England 1976).

    Google Scholar 

  • Richens, A. and Woodford, F.P.: Anticonvulsant Drugs and Enzyme Induction (Associated Scientific Publishers, Amsterdam 1976).

    Google Scholar 

  • Rigelman, S.; Rowland, M. and Epstein, W.L.: Griseofulvin-phenobarbital interaction in man. Journal of the American Medical Association 213: 426–431 (1970).

    Article  Google Scholar 

  • Roe, T.F.; Podosin, R.L. and Blaskovics, M.E.: Drug interaction: diazoxide and diphenylhydantoin. Journal of Pediatrics 87: 480–484 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Silver, J.: Vitamin D therapy for children on anticonvulsants. New England Journal of Medicine 293: 1106 (1975).

    PubMed  CAS  Google Scholar 

  • Sjö, O.; Hvidberg, E.F.; Naestoft, J. and Lund, M.: Pharmacokinetics and side effects of clonazepam and its 7-amino-metabolite in man. European Journal of Clinical Pharmacology 8: 249–254 (1975).

    Article  PubMed  Google Scholar 

  • Solomon, H.M. and Schrogie, J.J.: The effect of phenyramidol on the metabolism of diphenylhydantoin. Clinical Pharmacology and Therapeutics 8: 554–556 (1967).

    PubMed  CAS  Google Scholar 

  • Sutton, G. and Kupferberb, H.J.: Isoniazid as an inhibitor of primidone metabolism. Neurology (Minn.) 25: 1179–1181 (1975).

    Article  CAS  Google Scholar 

  • Vajda, F.J.E.; Prineas, R.J. and Lovell, R.R.H.: Interaction between phenytoin and the benzodiazepines. British Medical Journal 1: 346 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Vakil, S.D.; Critchley, E.M.R.; Philips, J.C.; Fahim, Y.; Haydock, C.; Cocks, A. and Dyer, T.: The effect of sodium valproate (Epilim) on phenytoin and phenobarbitone blood levels; Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the treatment of Epilepsy (MCS Consultants, England 1976).

    Google Scholar 

  • Viala, A.; Cano, J.P.; Dravet, L.; Tassinari, C.A.; Roger, J. and Angeletti-Philippe, A.: Blood levels of diazepam (Valium) and N-desmethyl diazepam in the epileptic child. Psychiatry, Neurology and Neurosurgery 74: 153–158 (1971).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, St. Bartholomew’s Hospital, London, EC1A 7BE, England

    Alan Richens

  2. Centre for Epilepsy, Chalfont St. Peter, Buckinghamshire, England

    Alan Richens

Authors
  1. Alan Richens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richens, A. Interactions with Antiepileptic Drugs. Drugs 13, 266–275 (1977). https://doi.org/10.2165/00003495-197713040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197713040-00002

Keywords

Search

Navigation